Last reviewed · How we verify

NCT06855966

Feasibility of ETCO₂ Changes During Passive Leg Raise for Fluid Management in Lung Surgery

Completed NA Last updated 4 March 2025
What this trial tests

NA trial testing 250 ml crystalloid bolus infusion in Lung Cancer in 53 participants. Completed in 15 March 2021.

Timeline
4 August 2020
Primary endpoint
14 March 2021
15 March 2021

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment53
Start date4 August 2020
Primary completion14 March 2021
Estimated completion15 March 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

18 and older, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: End tidal carbondioxide pressure (EtCO2) is an indirect indicator of cardiac output (CO) which is monitored in every patient at perioperative setting. The investigators aimed to use increase of EtCO2 as a response to passive leg raising maneuver (PLR) to indicate fluid responsiveness in patients who underwent lung resection with video-assisted thoracoscopic surgery (VATS).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. End-tidal CO<sub>2</sub> response to passive leg raise for fluid management in lung resections: A randomized controlled trial.
    Uzan HSA, Yuceyar L, Sayilgan NC. · · 2025 · PMID 41450995 · DOI 10.12669/pjms.41.12.12679

Verify or expand the search:

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06855966.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing